Header Logo

Connection

RUTH L KATZ to Lung Neoplasms

Back to Details
This is a "connection" page, showing publications RUTH L KATZ has written about Lung Neoplasms.
RUTH L KATZ
Connection Strength
0.918
Lung Neoplasms
  1. Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules. Cancer Cytopathol. 2020 08; 128(8):553-562.
    View in: PubMed
    Score: 0.151
  2. Activating enhancer-binding protein-2? nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection. Ann Thorac Surg. 2011 Sep; 92(3):1044-50.
    View in: PubMed
    Score: 0.083
  3. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res. 2010 Aug 01; 16(15):3976-87.
    View in: PubMed
    Score: 0.077
  4. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res. 2009 Mar; 7(3):330-8.
    View in: PubMed
    Score: 0.070
  5. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol. 2008 Sep; 3(9):979-84.
    View in: PubMed
    Score: 0.067
  6. Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer. Clin Cancer Res. 2005 Aug 01; 11(15):5417-24.
    View in: PubMed
    Score: 0.054
  7. RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells. Oncogene. 2005 May 12; 24(21):3409-18.
    View in: PubMed
    Score: 0.053
  8. Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays. Neoplasia. 2004 Sep-Oct; 6(5):623-35.
    View in: PubMed
    Score: 0.051
  9. Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer. J Cancer Res Clin Oncol. 2021 Aug; 147(8):2397-2405.
    View in: PubMed
    Score: 0.040
  10. Distinguishing Non-Small Cell Lung Cancer Subtypes in Fine Needle Aspiration Biopsies by Desorption Electrospray Ionization Mass Spectrometry Imaging. Clin Chem. 2020 11 01; 66(11):1424-1433.
    View in: PubMed
    Score: 0.039
  11. MiR-21, EGFR and PTEN in non-small cell lung cancer: an in situ hybridisation and immunohistochemistry study. J Clin Pathol. 2020 Oct; 73(10):636-641.
    View in: PubMed
    Score: 0.037
  12. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer. 2010 Dec 15; 127(12):2870-8.
    View in: PubMed
    Score: 0.020
  13. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest. 2011 Apr; 91(4):579-87.
    View in: PubMed
    Score: 0.020
  14. Computerized analysis of cytology and fluorescence in situ hybridization (FISH) in induced sputum for lung cancer detection. Cancer Cytopathol. 2010 Oct 25; 118(5):269-77.
    View in: PubMed
    Score: 0.019
  15. Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer. Lung Cancer. 2009 Oct; 66(1):58-63.
    View in: PubMed
    Score: 0.017
  16. Magnetic enrichment of bronchial epithelial cells from sputum for lung cancer diagnosis. Cancer. 2008 Aug 25; 114(4):275-83.
    View in: PubMed
    Score: 0.017
  17. Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer. Mod Pathol. 2008 Aug; 21(8):950-60.
    View in: PubMed
    Score: 0.016
  18. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res. 2007 Aug 15; 67(16):7901-6.
    View in: PubMed
    Score: 0.016
  19. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):482-7.
    View in: PubMed
    Score: 0.015
  20. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene. 2006 Apr 27; 25(18):2628-35.
    View in: PubMed
    Score: 0.014
  21. Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer. Int J Cancer. 2005 Aug 20; 116(2):285-90.
    View in: PubMed
    Score: 0.014
  22. Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations. Cancer. 2005 Feb 25; 105(1):35-43.
    View in: PubMed
    Score: 0.013
  23. Differentiating cytological features of bronchioloalveolar carcinoma from adenocarcinoma of the lung in fine-needle aspirations: a statistical analysis of 27 cases. Diagn Cytopathol. 1997 Mar; 16(3):253-7.
    View in: PubMed
    Score: 0.008
  24. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene. 2012 May 31; 31(22):2794-804.
    View in: PubMed
    Score: 0.005
  25. Role of immunocytochemistry in diagnosis of prostatic neoplasia by fine needle aspiration biopsy. Diagn Cytopathol. 1985 Jan-Mar; 1(1):28-32.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.